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Rapid detectionThe aim of this study was to develop a methodology to rapidly detect viable Mycobacterium avium subsp.
paratuberculosis (MAP) in clinical blood samples. MAP cells spiked into commercially available blood were re-
covered using optimised peptide-mediated magnetic separation (PMMS) and detected using a phage-based
method, and the identity of the cells detected conﬁrmed using nested-PCR ampliﬁcation of MAP signature se-
quences (IS900). The limit of detection was determined to be 10 MAP cells per ml of blood and was used to
detect MAP present in clinical bovine blood samples. Using the PMMS-phage method there was no difference
when detecting MAP from whole blood or from isolated buffy coat. MAP was detected in animals that were
milk-ELISA positive (15 animals) by PMMS-phage and no MAP was detected in blood samples from an
accredited Johne's disease free herd (5 animals). In a set of samples from one herd (10 animals) that came
from animals with variable milk ELISA status, the PMMS-phage results agreed with the positive milk-ELISA
results in all but one case. These results show that the PMMS-phage method can detect MAP present in
naturally infected blood. Total assay time is 48 h and, unlike PCR-based detection tests, only viable cells
are detected. A rapid method for detecting MAP in blood could further the understanding of disseminated in-
fection in animals with Johne's disease.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license. 1. Introduction
Mycobacterium avium subsp. paratuberculosis (MAP) is the causa-
tive agent of Johne's disease which is a wasting disease of cattle and
other ruminants that results in lower meat and milk yields, and sig-
niﬁcant ﬁnancial losses to both the dairy and beef industries
(Raizman et al., 2009). Paratuberculosis occurs throughout the
world and is considered endemic in many countries (Fridriksdottir et
al., 1999). MAP is transmitted vertically through contaminated milk
and colostrum or horizontally via contaminated feed (Whittington and
Sergeant, 2001). The disease can be controlled but early detection and
reliable diagnostics are paramount in stopping transmission between
animals. In Europe herd prevalence ranges from 7% to 55% but the sub-
clinical nature of the disease and the limitations of available diagnostic
tests can result in underreporting (Manning and Collins, 2001).
The identiﬁcation of MAP in the blood of animals susceptible to
Johne's disease has been carried out using techniques such as PCR
and culture (see Bower et al., 2010 for a review). The use of PCR,eparation; FPTB, FASTplaqueTB
ift).
.V. Open access under CC BY license. although rapid does not distinguish between live and dead organ-
isms. Culture is extremely slow and can take up to 16 weeks to
form colonies and in some cases requires decontamination, which
can reduce the number of viable cells in a sample (Grant et al.,
2003; Gumber and Whittington, 2007). Although Bower et al.
(2010) has indicated that some decontamination methods may affect
certain MAP strains more than others. Most recently Bower et al.
(2010) has described an optimised method for culture of MAP
from decontaminated erythrocyte-lysed washed buffy coat, with a
reported sensitivity of 10 MAP per ml of spiked whole blood, but
this still required up to 12 weeks incubation. Hence this long time re-
quired for culture can hamper efforts to understand different phases
of disease and determining when an animal develops disseminated
infection.
The FASTplaqueTB™ assay (FPTB; Lab21, UK) is a phage-based de-
tection method for human tuberculosis that has been adapted for the
detection of viable MAP in milk and cheese (Altic et al., 2007; Botsaris
et al., 2010; Stanley et al., 2007). To increase the speciﬁcity of the
method the phage-based assay was combined with PCR ampliﬁcation
of the multi-copy IS900 element. During the development of the
phage-based assay it was noted that substances present in the sample
matrix can inhibit phage infection. Sample processing was required to
ensure these are removed. Magnetic separation is a very simple
method of capturing and concentrating cells from a matrix using
magnet beads coated with a speciﬁc binding agent (either antibody
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beads described by Stratmann et al. (2006), have been used to recov-
er MAP cells from milk samples (Foddai et al., 2010).
The aim of this study was to combine existing technologies to de-
velop a novel protocol that could be used to rapidly detect MAP cells
in blood using a combined phage-PCR approach, and then to test
whether this could be used to detect viable MAP in clinical blood
samples.
2. Materials and methods
2.1. Bacterial strains, bacteriophage and growth media
MAP strains K10 and ATCC 19698 were used in the initial experi-
ments to optimise the phage assay. The Mycobacterium smegmatis
strain and the bacteriophage used (Actiphage) were those supplied
in the FASTPlaqueTB™ kit. All cultures of MAP were prepared using
FASTPlaqueTB™Media Plus (modiﬁed 7H9/OADCmedia) supplemented
with Mycobactin J (2 μg μl−1; Synbiotics Corporation, France).
To culture frombeads, 100 μl of each sample, after PMMS(Section2.3)
were inoculated on Herrold's egg yolk medium (HEYM) slopes sup-
plemented with Mycobactin J (BD, France). After inoculation, tubes
were incubated slanted with the caps lightly screwed at 37 °C. After one
week of inoculation slopes were examined for growth of contaminating
organisms. After two weeks the caps were sealed and the slopes incubat-
ed up right. The slopeswere then examined everyweek for 16weeks, and
every month up to six months after for growth. After six months, if there
was no visible growth, a slope wash detection method was carried out.
2.2. Slope wash detection of MAP growth
The slope wash was based on a method by Williams and Monif
(2009). Brieﬂy, 1 ml of sterile reverse osmosis (RO) water was
added to a slope with no visible growth. Using a sterile loop, the sur-
face of the agar was gently scraped to loosen any cells present. The
slopes were vortexed for 30 s and the liquid transferred to 1.5 ml
centrifuge tube and centrifuged (15 min, 17000 ×g). The supernatant
was removed, frozen at−80 °C and then rapidly thawed before boil-
ing for 10 min to induce cell lysis. The samples were then centrifuged
for 3 min (17000 ×g) and the supernatant (10 μl) used as template
DNA for PCR ampliﬁcation of IS900 (Section 2.6).
2.3. Preparation of peptide-coated magnetic beads
Biotinylated peptides were supplied by Cambridge Peptides Ltd.
Magnetic beads (Dynabeads - MyOne Tosylactivated, Invitrogen) were
individually coated with peptides aMp3 and aMptD (Stratmann et al.,
2006) according to the manufacturers' instructions.
2.4. Sample preparation and recovery of MAP cells from blood
For development of the assay, MAP cells were added to commer-
cial horse or sheep's blood (Oxoid, UK). To recover MAP cells, 1 ml
blood samples were diluted with 9 ml of Media Plus. Peptide mediat-
ed magnetic separation was performed using an adaptation of the
method described (Foddai et al., 2010) by adding 10 μl of peptide
coated beads (5 μl each of aMp3- and aMptD-coated beads) to each
sample and mixing at 18 rpm for 30 min (Dynabeads-MX mixer,
Invitrogen). Beads and bound MAP cells were recovered by centrifu-
gation at 4500 ×g for 15 min. The supernatant was removed and
the beads washed using 9 ml of fresh Media Plus. The beads were
again recovered by centrifugation (4500 ×g, 15 min) and ﬁnally
resuspended in 1 ml of Media Plus before being transferred into a
microcentrifuge tube for PMMS. Finally, the beads resuspended in 1
ml of Media Plus and Mycobacteria cells present detected using the
FPTB assay reagents.2.5. Detection and enumeration of MAP using the FASTPlaqueTB™ (FPTB)
assay
The FPTB (Lab21, Cambridge, UK) assay was carried out according
to the manufacturer's instructions. To perform the assay, samples
containing MAP are mixed with a broad spectrum mycobacteriophage;
D29. After the infection period any extracellular phage are inactivated
using a virucide; only phage that have successfully infected a cell are
protected from the virucide. The virucide is then neutralised by dilution
and infected cells are then plated in a lawn of fast growingM. smegmatis
using soft agar. Lysis of the infected cells releases new phagewhich then
infect theM. smegmatis cells and leads to the formation of a plaque in the
lawn. Hence each plaque formed represents oneMAP cell in the original
sample. Standard FPTB assay positive and negative controls were used
each time the assaywas performed. Enumeration ofMAP cells in inocula
wasdetermined using themodiﬁcation of the FPTB assay as described by
Rees and Botsaris (2012) which involves diluting samples until count-
able numbers of plaques are obtained (data reported as pfu ml−1).
2.6. PCR for the identiﬁcation of MAP cells
When a MAP cell is present in the initial sample, its DNA is pre-
served in the centre of the plaque (Stanley et al., 2007). Identiﬁcation
of the cell detected within single plaques was achieved by PCR ampli-
ﬁcation of IS900 signature sequences from this DNA using a modiﬁca-
tion of the plaque-PCR method described by (Botsaris et al., 2010). In
this study DNA was extracted from ﬁve plaques and concentrated
from plaque agar using Zymo-Gel DNA Recovery Spin Columns™,
(ZymoResearch, USA). IS900-speciﬁc nested PCR (Bull et al., 2003)
was performed using a 5 μl sample of DNA as template. Puriﬁed
MAP K10 DNA was used as a positive PCR control and DNA extracted
from plaques only containing M. smegmatis cells (the FPTB positive
control samples) as a negative control.
2.7. Detection of MAP in clinical blood samples
Blood samples were provided as superﬂuous material under the
Veterinary Surgeons Act as part of an on-going herd health screening
programme. The study protocol was approved by the University of
Nottingham, School of Veterinary Medicine and Science ethical re-
view panel prior to sample usage. Blood samples were collected
from nine cows, which had produced positive Johne's milk ELISA
test results on three separate occasions (Set A). Blood samples were
collected from ﬁve cows that belong to an accredited Johne's
disease-free herd (Set B). Before sampling, the site of venipuncture
was cleaned twice with alcohol. Blood was drawn into either sterile
sodium heparin Vacutainer tubes (for phage assay) or plain
Vacutainer tubes for blood ELISA. The blood ELISA was performed
by a commercial laboratory (Nationwide Laboratories, Leeds, UK).
2.8. Isolation of buffy coat and plasma
The isolation of the buffy coat from cows blood was carried out
using Ficoll-Paque Plus (GE Healthcare Life Sciences, UK). The buffy
coat layer from 2 ml of whole blood was isolated according to the
manufacturer's instructions. The plasma layer was also taken and
resuspended after the ﬁnal centrifugation in MP. The samples were
then processed as whole blood in Section 2.4.
3. Results
3.1. Optimisation of PMMS and sample preparation
To develop the method, MAP cells were spiked into commercially
available blood. To determine the efﬁciency of the PMMS recovery,
3.5 × 101 pfu.ml−1 was spiked into blood. Magnetic recovery of
Table 1
Limit of detection of phage assay in spiked sheep blood.
Approx. number of MAP
cells in inoculum (pfu)
Number of MAP
detected (pfu)
104 Conﬂuent a
103 TNTC b
102 151
101 9
100 0
a Conﬂuent: lysis of 80% to 90% of the lawn of M. smegmatis cells.
b TNTC: Too numerous to count; merging of plaques.
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90% loss of sample). Therefore magnetic recovery was replaced by
centrifugation which improved bead capture. Using this method,
when MAP was spiked into horse blood, still no cells were detectable.
However when sheep blood was used, 33% of the cells were recovered
(Fig. 1). Assuming that the blood was inhibiting either the peptide
binding or phage assay, the blood was diluted using FPTB Media
Plus. After dilution the number of MAP cells detected from samples
was signiﬁcantly higher (P b 0.01) than that recovered from the
undiluted blood, resulting in 92% recovery of MAP for a 1 in 10 dilu-
tion and 73% when a 1 in 50 dilution of the sample was used
(Fig. 1). Accordingly, a 1 in 10 dilution was adopted as the standard
method as it resulted in the most efﬁcient recovery of MAP cells.
3.2. Determining limit of detection of PMMS-phage method
The number of MAP cells in a liquid culture was ﬁrst determined
using the modiﬁed FPTB assay (Section 2.5). These cultures were
then diluted and spiked into sheep blood at different levels, down
to approximately 1 MAP cell per ml. Using these samples, it was
found that the optimised PMMS-phage method was able to reproduc-
ibly detect 10 MAP cells per ml of blood (Table 1).
3.3. Optimisation of nested-IS900 plaque-PCR
To conﬁrm the detection of MAP by the phage assay, Stanley et al.
(2007) extracted DNA from individual plaques and carried out a MAP
speciﬁc PCR. In this study DNA was extracted from 5 plaques using a
gel extraction kit and a nested-PCR (Bull et al., 2003) was used to am-
plify IS900 signature sequences. Using this approach IS900 DNA was
always ampliﬁed from DNA extracted from the ﬁve plaques. To con-
ﬁrm that it was still possible to detect the DNA from a single MAP
plaque within this sample, agar extracted from one MAP-positive
and four MAP-negative plaques were mixed together. Even at this
low concentration of target DNA, IS900 DNA was routinely detectable
(Fig. 2).
3.4. Detection of MAP in clinical blood samples
To determine whether the test developed in the laboratory was
applicable to clinical blood samples, the optimised method was
used to test bovine blood samples. Samples from a farm with a
known Johne's disease problem were obtained from nine animals***
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Fig. 1. Effect of blood on detection of MAP by PMMS-phage assay. Graph showing
plaque numbers recovered after performing the PMMS and phage assay on: Sample
1; MAP in 1 ml Media Plus. Sample 2; MAP in 1 ml of horse blood. Sample 3; MAP in
1 ml of sheep blood. Sample 4; MAP in 1 ml of sheep blood diluted 1:10 Media Plus.
Sample 5; MAP in 1 ml of sheep blood diluted 1:50 Media Plus. A One-way ANOVA,
followed by the Dunnett's test was used to analyse signiﬁcance (*P b 0.001) in the re-
duction of plaque number when compared to Sample 1. Error bars represent the stan-
dard deviations of the means of number of plaques recovered from the phage assay
performed in triplicate.that had given three positive milk-ELISA test results (Set A). In
addition ﬁve samples were obtained from an accredited Johne's
disease-free herd (Set B). For comparative purposes, blood ELISA as-
says were performed in parallel with the PMMS-phage method. All
of the animals in Set B gave negative blood ELISA results whereas all
animals in Set A gave a positive blood ELISA result, except cow 8
(Table 2).
The results from the PMMS-phage method showed viable MAP
cells were detected in all nine of the samples from Set A and no
MAP was detected in any samples from Set B (Table 2). Two of the
samples from Set B produced plaques (animal 11 and 13), but the
IS900 PCR did not detect any MAP DNA in these plaques indicating
that no MAP cells were detected.
3.5. Comparison of MAP detection from whole blood and the buffy coat
To determine whether the number of MAP cells detected could be
improved by isolation of the buffy coat layer, blood samples were
obtained from a second set of ten animals, which now included
cows that have given strong, intermediate or negative milk ELISA
test results at the last time of testing (Set C). Blood ELISA tests were
again performed, and antigens against MAP were detected in 4 out
of the 10 animals (Table 3).
Each blood sample was tested using the PMMS-phage method
both using whole blood and after buffy coat preparation. PCR-
positive MAP plaques were detected in eight of the ten blood samples
irrespective of the method of sample preparation, and there was no
signiﬁcant difference (P N 0.05) between the number of plaques iso-
lated from whole blood or from the buffy coat layer (Table 3). After
buffy coat isolation, the plasma fraction was recovered, but MAP
was not detected using the PMMS-phage method in these samples
(data not shown).
3.6. Culture of MAP following PMMS of blood
For the blood samples from Set C, culture was performed after
PMMS of both whole blood and buffy coat layers using 0.1 ml samples
plated onto Mycobactin J HEYM slopes. No chemical decontamination
was performed, and no loss of samples to contamination was seen.
However no growth was seen in any of the samples and the absence
of any detectable MAP growth was conﬁrmed using slope-wash and
direct IS900 PCR.Fig. 2. Conﬁrming detection of MAP DNA from mixed plaque samples. Nested-PCR
ampliﬁcation of the 300 bp IS900 DNA region speciﬁc for MAP (Bull et al., 2003).
Lane 1; DNA extracted from 5 M. smegmatis plaques. Lanes 2; DNA extracted from 5
MAP plaques. Lane 3; 4 MAP plaques mixed with 1 M. smegmatis plaque. Lane 4; 3
MAP plaques mixed with 2 M. smegmatis plaques. Lane 5; 2 MAP plaques mixed with
3 M. smegmatis plaques. Lane 6; 1 MAP plaque mixed with 4 M. smegmatis plaques.
Table 2
Results of analysis of blood samples from animals in Sets A and B.
Cow
Number
Milk ELISA Status
(3 tests)
Blood ELISA
Status
(OD Readings)
Plaque
Number a
IS900
Plaque
PCR
Set A 1 + + (190) 35 27 +
2 + + (N227) 15 13 +
3 + + (221) 19 25 +
4 + + (111) 31 31 +
5 + + (N227) 11 25 +
6 + + (N227) 10 10 +
7 + + (N227) 35 29 +
8 + − (1.47) 10 18 +
9 + + (193) 5 9 +
Set B 10 − − 0 0 NR
11 − − 2 0 −
12 − − 0 0 NR
13 − − 1 0 −
14 − − 0 0 NR
Numbers 1–9 represent Set A, Numbers 10–19 represent Set B and Numbers 10–14
represent set B.
NR - ‘not required’ shows there were no plaques formed, therefore no PCR required.
a – Values show the numbers of plaques obtained in two independently tested
samples.
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To give an indication of the reproducibility, the phage assay was
repeated for all blood samples twice, independently. There was a
good agreement (r2 = 0.73) between the two independent test re-
sults for each blood sample tested. The results gained for the
MAP-positive samples (Sets A and C) ranged from 3 to 35 pfu ml−1,
indicating that only low numbers of cells were detected. For MAP-
negative samples (deﬁned as plaques that were IS900-PCR negative)
the number of plaques was 5 or below (Tables 2 and 3).
4. Discussion
The use of PMMS to recover cells from the sample has two bene-
ﬁts; it allows concentration of cells and does not affect the viability
of MAP. The main obstacle for development of the assay was to
achieve efﬁcient capture of MAP cells in blood samples. Diluting the
blood sample 1 in 10 using modiﬁed Media Plus (modiﬁed 7H9
media) gave the best improvement in recovery of MAP cells from
spiked blood samples. The viscosity of horse blood is much higher
than that of sheep blood (Windberger et al., 2003) and therefore lim-
itation of bead movement in the sample may have hindered capture
of MAP cells. Interestingly, the addition of Media Plus to the bloodTable 3
Results of analysis of blood samples from Set C animals.
Cow Number Milk ELISA Status
(most recent a)
Blood ELISA Status Plaq
Who
15 Red − 20
16 Red + 3
17 Red + 22
18 Red + 12
19 Red − 13
20 Red + 8
21 Amber − 21
22 Green − 22
23 Green − 1
24 Green − 3
Red – denotes a strong positive Milk ELISA reading.
Amber – denotes an inconclusive Milk ELISA reading.
Green – denotes a negative Milk ELISA reading.
a Represents the most recent Milk-ELISA status.
b Values show the numbers of plaques obtained in two independently tested samples.samples induced lysis of the blood cells. This may have contributed
to the success of the assay when using clinical blood samples, since
any intracellular MAP cells would be released into the medium and
available for both PMMS and phage infection. This may also explain
why no difference was seen in the efﬁciency of MAP detection in
whole blood compared to isolated buffy coat layer. Thus negating
the need to prepare the buffy coat layer before testing blood samples
using this phage detection method.
The cows from Set A were selected using standard current diag-
nostic criteria for Johne's disease which requires repeat testing over
a period of six months. The blood ELISA results for these animals
agreed with this diagnosis in all but one case (cow #8) which gave
an indeterminate test result. In contrast the PMMS-phage method
detected viable organisms in blood samples from all animals in Set
A, and this result agreed with the milk ELISA results. In Set B, two
samples (animals 11 and 13) produced MAP DNA negative plaques,
which may be because the virucide did not destroy all the phage be-
fore plating in the lawn of M. smegmatis. Break-through has been
reported before when performing the FPTB assay but the introduction
of the PCR identiﬁcation step overcomes this problem. Hence in this
study samples are not scored as MAP-positive unless the IS900 se-
quence can be ampliﬁed from the plaque.
In Set C, three of the animals gave negative milk and blood ELISA
test results and two of these were also negative for MAP using the
PMMS-phage method. However the PMMS-phage method detected
viable MAP in the blood from one animal (cow #22), and the plaque
numbers were equivalent to those of the majority of the other milk
ELISA-positive animals. This indicates that results gained using a
method that directly detects the viable organism can differ from
test results based on the immune response of the animal to infection.
Further work is now needed to understand the relationship between
the immune response of the animal and the presence of viable organ-
isms in the blood.
When PMMS-phage MAP-positive samples were cultured, no
growth was detected. Since the plaque number indicates that there
were fewer than 42 MAP cells per ml in all of these samples, the
lack of growth is to be expected as this number is below the limit of
detection for the culture method used. MAP has been detected in
blood samples by PCR-based methods and culture (Bower et al.,
2010, 2011; Gwozdz et al., 2000; Naser et al., 2004). Although viable
cells can be cultured from these samples, the time required makes
this of limited practical value and the need for decontamination be-
fore culture may reduce the number of viable cells present in a sam-
ple (Reddacliff et al., 2003). Interestingly here, following PMMS of
blood samples, no contamination of cultures was seen suggesting
that the selectivity of the PMMS followed by the extensive washingue Number Plaque PCR Culture
le Blood b Buffy Coat b
25 38 42 + −
7 22 21 + −
15 28 32 + −
3 17 12 + −
23 15 5 + −
6 9 5 + −
11 32 31 + −
26 22 22 + −
1 2 0 − −
5 2 5 − −
179B.M.C. Swift et al. / Journal of Microbiological Methods 94 (2013) 175–179used in this method is sufﬁcient to remove contaminating microﬂora
from the sample without the need to apply chemical decontamination.
In contrast to culture, PCR-based MAP detection methods are more
rapid but they do not determine the viability of the cell detected. The re-
sults gained here show that the combined PMMS-phage-PCR assay can
achieve rapid detection and identiﬁcation of viable MAP in clinical sam-
pleswithin 48 h, and in addition provides an indication of the number of
cells present in the sample. The limit of detection determined here is in
agreement with an optimised MAP blood culture method reported by
Bower et al (2010) but this method requires a 12 week incubation be-
fore results are available.5. Conclusion
Here we have shown that we are able to detect viable MAP cells
from spiked blood samples within 48 h, with a limit of detection of
101 cells per millilitre of blood which can be combined with a sensi-
tive PCR assay that speciﬁcally identiﬁes the organism detected. The
method was also tested using clinical blood samples, by selecting an-
imals that were presumptively identiﬁed as having Johne's disease on
the basis of repeated milk ELISA test results. Although this study was
limited to small sample set, this is the ﬁrst demonstration of a new
method that can directly detect viable organisms in blood. This
assay will allow researchers to better understand the development
of disseminated infection, and may therefore lead to a better under-
standing of the pathogenesis of the disease and the immune response
of the animal (Bower et al., 2010). In addition we believe that the
assay could also be applied to blood samples from all susceptible an-
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